| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |